Quantum Surgical SAS Revenue and Competitors

Montpellier, France

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Quantum Surgical SAS's estimated annual revenue is currently $32.4M per year.(i)
  • Quantum Surgical SAS's estimated revenue per employee is $251,000

Employee Data

  • Quantum Surgical SAS has 129 Employees.(i)
  • Quantum Surgical SAS grew their employee count by 5% last year.

Quantum Surgical SAS's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.6M1269%N/AN/A
#2
$65.8M2623%N/AN/A
#3
$55.7M22247%N/AN/A
#4
$43.4M173-9%N/AN/A
#5
$32.4M1295%N/AN/A
#6
$115M4589%N/AN/A
#7
$36.4M1459%N/AN/A
#8
$143.7M409-11%€83.1MN/A
#9
$32.4M1292%N/AN/A
#10
$2571.2M102444%N/AN/A
Add Company

What Is Quantum Surgical SAS?

Quantum Surgical SAS is a privately-funded medical device company headquartered in Montpellier, south of France. At Quantum Surgical, we are passionate about creating groundbreaking computer-assisted solutions for the benefit of patients, physicians, and hospitals. Check our website for open positions and apply online!

keywords:N/A

N/A

Total Funding

129

Number of Employees

$32.4M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Quantum Surgical SAS News

2022-04-19 - Dallas Invents: 142 Patents Granted for Week of March 29

Abstract: A surgical instrument includes a mount body, ... or more parties and implementing a quantum optimizer to analyze the communication...

2021-10-26 - Quantum Surgical Secures 40 Million Euros to Support the Commercial Launch of Epione Its unique Medical Robot

Montpellier, France, October 19th, 2021 – Quantum Surgical, an innovative medical robotic company, announced today that it has secured €40 million (US$48 million) of financing. Led by existing key investor Ally Bridge Group (“ABG”) with an investment of €20 million (US$24 million), this round al ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20M1335%N/A
#2
$33.6M1348%N/A
#3
$13.9M1369%N/A
#4
$19.7M1360%N/A
#5
$25.3M14450%N/A